Literature DB >> 9650745

Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain.

A Takeda1, T Yasuda, T Miyata, Y Goto, M Wakai, M Watanabe, Y Yasuda, K Horie, T Inagaki, M Doyu, K Maeda, G Sobue.   

Abstract

In the previous study [Takeda et al. (1996) Neurosci Lett 221: 17-21], we reported that the advanced glycation end products (AGEs) in the external space of neuronal perikarya (extraneuroperikaryal AGE deposits) were significantly abundant in the Alzheimer's brain. In this study, we investigated the spatial relationship of the extraneuroperikaryal AGE (carboxymethyllysine and pentosidine) deposits in astrocytes and microglial cells in the Alzheimer's disease brain using double immunolabelling for AGEs and astrocyte or microglial cell markers. Most of the extraneuroperikaryal AGE deposits were co-localized with glial fibrillary acidic protein-positive astrocytes. AGE deposit-bearing astrocytes also contained Gomori-positive granules. Furthermore, some of the extraneuroperikaryal AGE deposits were co-localized with microglial cells. These extraneuroperikaryal AGEs may activate astrocyte and microglia, and play a role in pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650745     DOI: 10.1007/s004010050839

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

Review 2.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 3.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

4.  Excessive Zinc Ion Caused PC12 Cell Death Correlating with Inhibition of NOS and Increase of RAGE in Cells.

Authors:  Sai-Ya Zhang; Jing-Jing Liang; Yan-Qiang Liu
Journal:  Cell Biochem Biophys       Date:  2022-09-06       Impact factor: 2.989

Review 5.  Oxidative stress in diabetes and Alzheimer's disease.

Authors:  V Prakash Reddy; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

6.  Anthocyanins Reversed D-Galactose-Induced Oxidative Stress and Neuroinflammation Mediated Cognitive Impairment in Adult Rats.

Authors:  Shafiq Ur Rehman; Shahid Ali Shah; Tahir Ali; Jong Il Chung; Myeong Ok Kim
Journal:  Mol Neurobiol       Date:  2016-01-06       Impact factor: 5.590

7.  Involvement of Maillard reactions in Alzheimer disease.

Authors:  V Prakash Reddy; Mark E Obrenovich; Craig S Atwood; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

8.  D-ribose induces cellular protein glycation and impairs mouse spatial cognition.

Authors:  Chanshuai Han; Yang Lu; Yan Wei; Ying Liu; Rongqiao He
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

9.  D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation.

Authors:  C Han; Y Lu; Y Wei; B Wu; Y Liu; R He
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

10.  Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression.

Authors:  Vijayasree V Giridharan; Rajarajan A Thandavarayan; Somasundaram Arumugam; Makoto Mizuno; Hiroyuki Nawa; Kenji Suzuki; Kam M Ko; Prasanna Krishnamurthy; Kenichi Watanabe; Tetsuya Konishi
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.